Skip to main content
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · IEX Real-Time Price · USD
4.390
-0.050 (-1.13%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Orchestra BioMed Holdings Revenue

In the year 2023, Orchestra BioMed Holdings had annual revenue of $2.76M, a decrease of -21.88%. Revenue in the quarter ending December 31, 2023 was $262.00K, a -76.25% decrease year-over-year.

Revenue (ttm)
$2.76M
Revenue Growth
-21.88%
P/S Ratio
56.91
Revenue / Employee
$49,286
Employees
56
Market Cap
157.06M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.76M-773.00K-21.88%
Dec 31, 20223.53M4.32M-551.79%
Dec 31, 2021-782.00K-6.49M-113.71%
Dec 31, 20205.70M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

OBIO News

More News